Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,292,000 | 4,951,000 | 2,493,000 | 7,197,000 | 5,352,000 |
| Depreciation Amortization | 1,506,000 | 1,027,000 | 502,000 | 1,869,000 | 1,347,000 |
| Income taxes - deferred | -424,000 | -429,000 | -191,000 | -720,000 | -508,000 |
| Accounts receivable | -384,000 | -622,000 | -251,000 | -685,000 | -710,000 |
| Other Working Capital | 278,000 | -768,000 | -149,000 | 1,331,000 | -66,000 |
| Other Operating Activity | 402,000 | 622,000 | 251,000 | 1,603,000 | 1,628,000 |
| Operating Cash Flow | $8,670,000 | $4,781,000 | $2,655,000 | $10,595,000 | $7,043,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -907,000 | -481,000 | -243,000 | -1,927,000 | -1,138,000 |
| Net Acquisitions | -330,000 | -300,000 | N/A | -2,812,000 | -2,781,000 |
| Purchase Of Investment | -9,121,000 | -5,654,000 | -3,103,000 | -7,590,000 | -5,064,000 |
| Sale Of Investment | 7,508,000 | 4,684,000 | 2,512,000 | 8,062,000 | 4,673,000 |
| Other Investing Activity | -91,000 | -113,000 | -16,000 | -259,000 | -104,000 |
| Investing Cash Flow | $-2,941,000 | $-1,864,000 | $-850,000 | $-4,526,000 | $-4,414,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 313,000 | 332,000 | 147,000 | 3,062,000 | 1,633,000 |
| Debt Issued | 16,000 | 16,000 | 19,000 | 1,023,000 | 1,013,000 |
| Debt Repayment | -1,000 | -1,000 | 1,000 | -196,000 | -108,000 |
| Common Stock Issued | 434,000 | 311,000 | 125,000 | 311,000 | 240,000 |
| Common Stock Repurchased | -985,000 | -760,000 | -407,000 | -1,183,000 | -941,000 |
| Dividend Paid | -2,404,000 | -1,559,000 | -713,000 | -2,746,000 | -2,033,000 |
| Other Financing Activity | -1,114,000 | -911,000 | -675,000 | -4,134,000 | -1,621,000 |
| Financing Cash Flow | $-3,741,000 | $-2,572,000 | $-1,503,000 | $-3,863,000 | $-1,817,000 |
| Exchange Rate Effect | -17,000 | -41,000 | -42,000 | 277,000 | 144,000 |
| Beginning Cash Position | 5,377,000 | 5,377,000 | 5,377,000 | 2,894,000 | 2,894,000 |
| End Cash Position | 7,348,000 | 5,681,000 | 5,637,000 | 5,377,000 | 3,850,000 |
| Net Cash Flow | $1,971,000 | $304,000 | $260,000 | $2,483,000 | $956,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,670,000 | 4,781,000 | 2,655,000 | 10,595,000 | 7,043,000 |
| Capital Expenditure | -1,142,000 | -714,000 | -292,000 | -2,262,000 | -1,472,000 |
| Free Cash Flow | 7,528,000 | 4,067,000 | 2,363,000 | 8,333,000 | 5,571,000 |